Table 3.

Testing predictors for 3-month prognosis in validation cohort.

	Multivariate 1			Multivariate 2
	HR	95% CI	p	HR	95% CI	p
Liver cirrhosis	2.40	1.12–5.15	0.024	2.53	1.17–5.47	0.019
Total bilirubin (μmol/L)	1.01	1.00–1.01	0.000	1.01	1.00–1.01	0.000
PT-INR	2.48	1.42–4.31	0.001	2.37	1.35–4.17	0.003
Infection	1.82	1.27–2.60	0.001	1.86	1.30–2.67	0.001
Hepatic encephalopathy	3.50	1.79–6.87	0.000	3.23	1.63–6.43	0.001
Sessions of ALSS therapy				0.84	0.71–0.98	0.031

HR hazard ratio, CI Confidence interval, PT-INR international normalized ratio (INR) of prothrombin time (PT), ALSS artificial liver support system.